Avalo Therapeutics (AVTX) Stock Price & Financial Analysis
Avalo Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Avalo Therapeutics
What is the current stock price for AVTX?
As of the latest trading session, AVTX stock trades at $16.27. The 52-week range is $3.39–$24.27, with a day range of $15.29–$17.21.
What is the P/E ratio for AVTX?
The P/E ratio (Price-to-Earnings) for AVTX is shown in the Key Statistics section. This valuation metric helps compare Avalo Therapeutics, Inc. to industry peers.
Does AVTX pay dividends?
Avalo Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for AVTX?
Based on 4 analysts, the consensus for AVTX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of AVTX?
Avalo Therapeutics's market capitalization is $218.1M, classifying it as a micro-cap company. Avalo Therapeutics operates in the Healthcare sector within the Biotechnology industry.